Company Snapshot
Analysis and scenarios: ChatGPT.
Inter & Co — INTR | Nasdaq | Brazil | Digital banking and fintech
Inter combines everyday banking, payments, lending, investing, insurance and digital commerce. The thesis rests on monetizing a growing customer base faster than costs grow.
| Field | Current view |
|---|---|
| Thesis | Profit, efficiency and capital improved, but 90+ day delinquency still rose |
| Confidence | Medium: Q3 confirms scale, but the credit turnaround is incomplete |
| Horizon | Three years, to November 2029 |
| Investment type | Growth bank with room for higher ROE and direct exposure to Brazil and BRL |
| Opportunity | Active customer monetization, inexpensive funding and operating leverage |
| Risk | Credit losses could consume incremental interest income |
| Next results | Q4 2026; date not yet researched under the two-month rule following November 12 |
| Updated | November 16, 2026; Q3 reported November 12, call November 13 |
Q3 showed 46.8m customers, 27.1m active customers, BRL 425m net income attributable to shareholders and 15.8% ROE. Early delinquency improved but 90+ delinquency rose to 5.3%. Watch revenue per customer against cost to serve, margin after credit losses, and mature private-payroll cohorts. Product ROE of about 30% is management's estimate for the product, not group ROE. Q3 marked a second capital-neutral quarter: CET1 rose from 11.5% to 12.2% as lending grew, though Tier 2 also helped the overall Basel ratio. Q3 results · Q3 presentation · IFRS statements
Investment Thesis
Inter can become a more profitable bank without increasing its cost base at the same pace. Existing customers and low-cost transaction deposits support activation, credit use and fee services.
- Monetization. The existing distribution allows more products to be sold without paying full acquisition cost for each increment of revenue.
- Operating leverage. Q3 net revenue grew about 26% year on year against 17% operating expense growth; efficiency improved to 41.9% from 45.2% a year ago and 42.1% in Q2.
- Returns and capital generation. ROE rose 1.6 points year on year to 15.8%, down from 16.3% in Q2. CET1 rose 0.7 points to 12.2%; returns are improving unevenly.
The thesis requires growth after credit losses, deeper primary-banking relationships and higher ROE driven by economics rather than leverage. The opportunity is sustainable ROE; credit costs are the principal test. Q3 results · Q3 presentation · IFRS statements
The Business
Inter operates as a digital bank and financial-services ecosystem. Accounts and payments attract customers and transactional deposits; lending, investments, insurance and other services deepen relationships and monetization.
The main economic engine is banking: income from loans and other interest-bearing assets less funding costs and credit losses. Fee services add revenue and may reduce dependence on the credit cycle.
Secured loans, mortgages, home equity and payroll lending form an important foundation. Credit cards, PIX credit and installment financing expand both opportunity and risk. Private payroll loans are made to private-sector employees and collected through salary deductions; changing employers can disrupt collections. This product is not risk-free secured lending either.
Brazil is central to the thesis. International accounts and US expansion offer additional options, but the base case should rest on Brazilian banking economics. 2Q26 transcript; Owners’ Day 2026
Competitive Advantages
Funding. Quarterly funding cost rose to 70.0% of CDI in Q3; management estimates 67.9% adjusted for business days and about 66% over the last twelve months. Rates and deposit mix remain risks.
Distribution. 27.1m active customers, around 22m daily logins and about 9% of PIX transactions give Inter an existing channel for more products.
Low marginal costs. Cost to serve was nearly unchanged at BRL 13.3 per month. Management reports about 4,300 employees and 85% of contacts handled with AI. Data across transactions, income and products can help underwriting and personalization if realized margins and loss outcomes confirm it.
The moat is moderate and developing. Nubank, incumbent banks and other fintechs compete; product breadth alone is not proof of pricing power or loyalty.
Growth Drivers
| Growth driver | How it may create value | What to verify |
|---|---|---|
| Activation and primary banking | More payments, deposits and products per customer | Active customers, transactional deposits, ARPAC |
| Private payroll | Higher-revenue customers and deeper relationships | Cohort losses, relinkage after job changes, margin after risk |
| Credit cards | More interest-bearing and installment balances | Revenue versus provisions |
| Mortgages and home equity | Growth in secured lending | Returns after funding, collateral and capital intensity |
| Entrepreneurs and small businesses | Accounts, payments, acquiring, investments and loans | Monetization, deposits and SME credit quality |
| Fee services | Insurance, investments, subscriptions and in-app advertising | Actual net fee growth |
In 2Q26, Inter had 2.9 million business customers, up 24% year over year. Management cited their ARPAC at 2.8 times average and private payroll customers' ARPAC at 3.7 times average. Higher ARPAC does not prove equally high profitability after losses.
In Q2 Inter had 2.9m business customers, up 24%; management put their ARPAC at 2.8× the average and that of private-payroll customers at 3.7×. Higher ARPAC does not establish profitability after losses. Subscriptions, Inter Ads, credit insurance and AI personalization offer further opportunities. Management reports over 700 AI models in production and 85% of requests handled without human support; stable cost to serve is a reported indicator, not separately measured AI profit. Q3 results · Q3 presentation · IFRS statements
Economics & Financial Profile
Operating leverage, slower quarterly growth. Q3 net income attributable to shareholders was BRL 425m versus BRL 336m a year earlier (+26%) and BRL 421m in Q2 (+1%). ROE of 15.8% compares with 14.2% a year earlier and 16.3% in Q2. Management attributed the sequential decline to a one-off Q2 IPCA contribution and higher average equity.
Risk-adjusted margins. NIM 2.0 was 9.96% versus 10.12% in Q2 and up 68 bp year on year; risk-adjusted NIM 2.0 fell to 5.74% from 5.86%. The credit mix and provisions need to be read together.
Mixed credit quality. All-in cost of risk stayed at 5.9%. Expanded-portfolio 15–90 day delinquency fell from 4.5% to 4.2% and NPL formation from 1.83% to 1.74%; 90+ days rose from 5.0% to 5.3%. Private-payroll NPL formation fell from 4.9% to 3.2%, while Stage 3 formation rose from 4.8% to 5.8%. Management links early improvement to automated relinkage; mature-cohort recovery is unproven.
Capital. Banco Inter CET1 rose from 11.5% to 12.2%, Basel ratio from 14.4% to 15.6%, and the holding company reported BRL 2.1bn in excess capital. Profit added about 1.0 point to CET1, growth and risk used 0.7 points, and other net factors added 0.3. Tier 2 issuance supported the Basel ratio, which does not all reflect organic common-equity generation. Q3 results · Q3 presentation · IFRS statements
Key KPIs
| KPI | Q3 2026 | Significance |
|---|---|---|
| Total / active customers | 46.8m / 27.1m | Distribution and usage |
| Net revenue | BRL 2.718bn; +26% YoY | Monetization |
| Net income attributable to shareholders | BRL 425m; +26% YoY, +1% QoQ | Earnings after risk and costs |
| ROE | 15.8% | Return on equity |
| Efficiency ratio | 41.9% | Operating leverage |
| NIM 2.0 / risk-adjusted | 9.96% / 5.74% | Margins before and after losses |
| Expanded credit portfolio | BRL 58.1bn; +25% YoY, +5% QoQ | Credit and private debt |
| Funding / funding cost | BRL 81.0bn / 70.0% CDI; 67.9% normalized for business days | Scale and cost |
| Net ARPAC / cost to serve | BRL 35.6 / 13.3 monthly | Revenue against servicing costs |
| 90+ / 15–90 day NPL | 5.3% / 4.2%, expanded methodology | Late deterioration, early improvement |
| All-in cost of risk / coverage | 5.9% / 135% | Loss costs and reserves |
| Diluted EPS / diluted shares | BRL 0.95 / 448.70m | Per-share earnings and dilution |
| Banco Inter CET1 / Basel ratio | 12.2% / 15.6% | Capital; Tier 2 partly explains Basel improvement |
The expanded denominator lowers the reported NPL percentage. Reducing the card write-off window from 360 to 330 days lowered reported NPL by about 30 bp without changing cost of risk. According to Inter, Desenrola reduced Q3 cost of risk around 20 bp and raised Stage 3 formation around 30 bp; these changes do not necessarily reflect cash collections. ARPAC, NIM, efficiency and NPL use company non-IFRS definitions. September 30 quarter, reported November 12; call November 13. Q3 results · Q3 presentation · IFRS statements
Management & Capital Allocation
Leadership. João Vitor Menin is Global CEO, Alexandre Riccio SVP COO, Santiago Stel SVP CFO and Francisco Santos SVP Chief Growth Officer. The Q3 presentation confirmed responsibilities for credit and operations, profitability and capital allocation, and growth and monetization. Benefits are management intentions; continued risk-adjusted returns are needed to substantiate them.
Strategic horizons. The original 60–30–30 plan targeted 60m customers, 30% efficiency and 30% ROE by end-2027. May 2026 Owners' Day set a path to roughly 28% ROE (26–30%) by end-2029. The Rule of 50 combines annual net revenue growth and ROE over 2026–29; Q3 achieved 26% + 15.8% = 41.8%. This is a management framework, not an accounting measure.
Governance. The October 13 ownership breakdown shows Costellis with 25.65% of economic ownership and 77.53% of votes. Class B has ten votes per share; 441,543,223 shares comprise 328,290,095 Class A and 113,253,128 Class B. The class mix changed without increasing aggregate shares. Ownership breakdown.
BDR facility. On November 10 Bradesco completed Nasdaq sales of all 12,281,668 existing Class A shares corresponding to BDRs without a valid election. There was no issuance or dilution, although concentrated sales could temporarily have increased supply. Final BRL proceeds per BDR and payout date had not been disclosed as of November 16. Form 6-K · BDR FAQ. Q3 results · Q3 presentation · IFRS statements
Risks / Bear Case
Card-heavy loan growth raises consumer exposure and may mask problems in more mature cohorts. Private payroll remains the primary credit test. Automated relinkage began in September; NPL formation improved from 4.9% to 3.2% and management reports recovery of payroll deductions on roughly 30% of troubled balances, but Stage 3 formation went from 4.8% to 5.8%. About 40% insurance penetration mitigates some risk without replacing underwriting.
Brazilian rates, employment and fiscal conditions affect repayments and funding. A weaker BRL can diminish USD returns even as local earnings grow. Competition can raise deposit costs and impede primary relationships. Leverage can enhance ROE without underlying improvement; ROA, capital and risk-weighted assets also matter. The adverse case is that credit losses, funding and FX consume the benefits of growth, leaving earnings stagnant and limiting the multiple. Q3 results · Q3 presentation · IFRS statements
Valuation
ChatGPT produces the calculations and valuation scenarios. Share-price inputs are dated to the analysis; they are not continuously updated market data.
Different outcomes. Different values.
4.15 USD · November 13, 2026 · regular close
Price attractiveness: 7.7/10, based on USD 4.15 for Class A INTR, Nasdaq regular close on November 13, 2026. Assessed November 16, 2026, through November 16, 2029 under methodology 1.2; previously 7.8/10 at USD 3.86 on November 6. Price history.
The October 13 share count of 441,543,223 implies indicative market capitalization of USD 1.83bn. Q3 diluted EPS was BRL 0.95 on 448.70m weighted diluted shares; BRL 11.05bn attributable equity implies BRL 25.01 per undiluted share. At an illustrative BRL 5.60/USD, annualizing quarterly EPS gives about USD 0.68, or 6.1× at USD 4.15, and about 0.9× book. The price and share count are not synchronous; these are neither TTM nor forward multiples. The close was 7.5% above November 6 and 4.7% above the USD 3.97 earnings-day close of November 12. The BDR facility may have affected supply, but its price impact cannot be isolated.
| Item | Base | Adverse |
|---|---|---|
| 2029 attributable annual profit | BRL 2.4bn, versus BRL 1.70bn annualized Q3, about 12% annual growth; no need for management's 28% ROE target | BRL 1.2bn; persistent rates, weak demand, fiscal/FX pressure and cost of risk over 7% |
| Capital / diluted shares | Deposits and retained earnings support most growth; 470m shares | More capital needed; 510m shares |
| BRL per USD | 5.80 | 7.00 |
| P/E | 10× | 7× |
| Annual diluted EPS | BRL 5.11 / USD 0.88 | BRL 2.35 / USD 0.34 |
| Three-year price | USD 8.80 | USD 2.35 |
| Three-year dividends | USD 0.20 | USD 0.00 |
| Total return | +117.0% | −43.3% |
Price is annual attributable profit divided by diluted shares and the BRL/USD rate, times P/E. Total returns use unrounded prices and include non-reinvested dividends before taxes, fees and CZK effects. Debt and dilution are not deducted twice. The March 2, 2026 BRL 259.6m dividend is historical; USD 0.20 is a modeled assumption, not an approved distribution. Scenario prices are not discounted present values. Confidence is medium: historical data are documented; credit losses, FX, multiples, dividends and share count remain assumptions. Higher entry price narrows the return cushion despite stronger Q3 profitability and capital. Q3 results · Q3 presentation · IFRS statements
The central risk is the joint sensitivity of earnings per share and USD valuation to credit losses, capital needs and BRL. With the scenarios unchanged, a price below USD 3.50 would improve the assessment, while a return above USD 5.50 would remove much of the cushion. Stabilizing BRL, stronger risk-adjusted margins and growth without forced capital would help; a cost of risk above 7% with falling risk-adjusted margin, a weaker currency or more dilution would hurt. A price decline alone does not raise the score without checking the cause.
What Would Change the Assessment?
The following thresholds are analytical conditions of this thesis, not company guidance.
| Signal | What it would mean |
|---|---|
| Cost of risk above 7% for two quarters alongside declining margin after risk | Higher yields no longer compensate for credit losses |
| Rising delinquency in mature private payroll cohorts despite operational changes | The problem may go deeper than collection timing |
| ROE below 15% for two quarters without a clear one-off explanation | Continuing return improvement is challenged |
| Stagnant net ARPAC alongside rising cost to serve | Monetization fails to deliver expected leverage |
| Loan growth again requires substantial external capital | Capital self-sufficiency was not durable |
| Repeated methodological changes without clear comparable data | Reduced visibility into actual trends |
Confidence would instead increase with profit and ROE growth accompanied by stable or improving margin after risk, healthier mature cohorts, a continuing decline in the efficiency ratio and growing fee services.
Current View
November 16, 2026: strength 6.7/10; price attractiveness 7.7/10 at USD 4.15. Q3 supports scale, monetization, operating leverage and capital, but 90+ NPL rose to 5.3% and risk-adjusted NIM fell sequentially. Scenario prices remain USD 8.80 and USD 2.35 with returns of +117.0% and −43.3%. Customer growth and strategy alone do not establish sustainable earnings and ROE. Confidence is medium; historical figures are more certain than the 2029 estimates. The Q4 date has not yet been researched; under the two-month rule verification starts after January 12, 2027. Watch Stage 3 and 90+ delinquencies, risk-adjusted NIM, cost of risk around 6%, capital generation and EPS.
| Area | Score | Evidence |
|---|---|---|
| Competitive advantage | 6.1/10 | 27.1m active customers, about 9% of PIX, BRL 81bn funding and approximately 66% of CDI LTM; pricing power not proven |
| Demand durability | 8.0/10 | Accounts, payments, savings and credit meet durable needs; 31m daily transactions; credit cycle matters |
| Management execution | 6.1/10 | BRL 425m profit, 41.9% efficiency and better early metrics; net income only +1% QoQ and 90+ NPL 5.3% |
| Business economics | 7.1/10 | Diluted EPS BRL 0.75 to 0.95 YoY, margin per active customer BRL 22.3, ROE 15.8%; risk-adjusted NIM fell to 5.74% QoQ |
| Financial resilience | 6.3/10 | CET1 12.2%, Basel 15.6%, funding +19% YoY and BRL 2.1bn holding excess capital; Basel partly Tier 2, cost of risk remains 5.9% |
The equally weighted average is 6.72, rounded to 6.7. Competitive advantage, execution, economics and resilience rose by 0.1–0.3, while demand durability stayed at 8.0. Further stable or rising margins after risk and lower mature-cohort arrears could support higher scores. Cost of risk above 7% with falling risk-adjusted margins, or ROE below 15% for two quarters absent a one-off, would weaken the assessment. Q3 results · Q3 presentation · IFRS statements
Thesis History / Updates
| Period | Demonstrated development | Thesis impact |
|---|---|---|
| Q2 2025 | Earnings BRL 315 million; ROE 13.9% | Monetization and profitability gradually improve |
| Q3 2025 | Earnings BRL 336 million; ROE 14.2% | Returns continue improving |
| Q4 2025 | Earnings BRL 374 million; ROE 15.1% | Further improvement in capital returns |
| Q1 2026 | Earnings BRL 395 million; ROE 15.5%; efficiency ratio 43.8% | Operating leverage confirmed; greater attention to credit losses |
| May 2026 | Rule of 50 and ROE trajectory around 28% by 2029 | Updated strategic horizon |
| Q2 2026 | Earnings BRL 421 million; ROE 16.3%; efficiency ratio 42.1% | Further results improvement and a capital self-sufficiency milestone |
| Revision October 8, 2026 | Credit risk, write-off methodology and the shifted target horizon incorporated | Operational thesis strengthens; risk requires separate verification |
| Partial review October 10, 2026 | First two scores under methodology 1.0; October 9 close of USD 7.68; capital series and BDR timetable added | Operational thesis unchanged on available evidence; valuation now includes dividends, dilution and adverse BRL movements |
| Partial review October 12, 2026 | Indexed official calendar states Q3 2026 release on November 12 and call on November 13; the last closing quote is still USD 7.68 on October 9. | Both scores and model assumptions unchanged; the next thesis test is more precisely dated. Coverage of newer evidence remains incomplete. |
| Partial review October 19, 2026 | October 13 management changes and ownership; BDR timetable reached the October 19 transition; October 16 INTR close of USD 6.73 | Business strength 6.6/10, price attractiveness 6.5/10 under methodology 1.2; operating assumptions unchanged, three-year returns +82.1% / −46.1%. |
| Partial review October 26, 2026 | October 19 6-K confirmed the subsequent BDR period, INBR34 trading and ongoing sales facility; October 23 INTR close of USD 7.19 | Business strength unchanged at 6.6/10; price attractiveness 6.3/10. Operating assumptions unchanged, three-year returns +70.5% / −49.5%. |
| October 26, 2026 — intraday post-election update | INTR USD 4.61 at 11:55 EDT; broad Brazilian selloff and weaker BRL. Analytical earnings, currency, dilution, dividend and multiple assumptions tightened. | Price attractiveness 7.4/10 under 1.2; latest business strength 6.6/10 retained. New three-year prices USD 8.80 / 2.35, total returns +95.3% / −49.0%. |
| November 2, 2026 partial review | USD 4.01 regular close October 30; the BDR facility result was not yet disclosed | Strength 6.6 and attractiveness 7.8; unchanged scenarios +124.5% / −41.3% |
| November 9, 2026 partial review | USD 3.86 regular close November 6; the BDR facility result was not yet disclosed | Strength 6.6 and attractiveness 7.8; unchanged scenarios +133.3% / −39.0% |
| Q3 2026 / November 16 partial review | BRL 425m earnings; ROE 15.8%; efficiency 41.9%; CET1 12.2%; 90+ and 15–90 day NPL 5.3% and 4.2%. BDR sales completed for 12.28m existing shares | Strength 6.7 on scale, economics and capital; price attractiveness 7.7 at USD 4.15; scenarios +117.0% / −43.3% |
Historical quarterly earnings and ROE use the comparison series in Q2 2026 earnings release, page 13. These records track thesis evidence rather than pretend to document earlier investment decisions.
Rating history and review coverage
| Assessment / record date | Business strength | Price Attractiveness | Price and quote date | Methodology / reason |
|---|---|---|---|---|
| October 8, 2026 — historical analysis revision | No numerical score provided. | No numerical score provided. | USD 7.30, intraday quote October 8, 2026 at 14:10 EDT. | Original illustrative 2029 prices: weak execution USD 4–6, average to good USD 10–14, strong USD 17–24; 450 million shares and BRL 5.20/USD. This was not a methodology 1.0 assessment and cannot be directly compared with the new scores. |
| October 10, 2026 — first methodological assessment | 6.6/10. | 6/10. | USD 7.68, closing price October 9, 2026. | 1.0; demonstrated Q2 2026 results and earlier periods, explicit three-year scenarios. Further price increases alone do not change the business score. |
| October 12, 2026 — partial review | 6.6/10, component scores 6 / 8 / 6 / 7 / 6 unchanged. | 6/10, unchanged. | USD 7.68, October 9, 2026 close, verified again October 12. | 1.0; available evidence does not change the business thesis, price or scenarios. Three-year horizon now ends October 12, 2029. Planned Q3 2026 dates added. |
| October 19, 2026 — partial review | 6.6/10; areas 6.0 / 8.0 / 6.0 / 7.0 / 6.0. | 6.5/10. | USD 6.73, October 16, 2026 close. | 1.2; lower price, unchanged business scenario, new three-year horizon through October 19, 2029. Management and BDR changes do not yet change the economic evidence. |
| October 26, 2026 — partial review | 6.6/10; areas 6.0 / 8.0 / 6.0 / 7.0 / 6.0 unchanged. | 6.3/10. | USD 7.19, October 23, 2026 close. | 1.2; higher starting price on unchanged operating scenarios reduces attractiveness versus October 19; new BDR 6-K does not change business evidence. |
| October 26, 2026 — intraday update after Brazil's election | 6.6/10, latest assessment retained; no new five-area reassessment performed. | 7.4/10. | USD 4.61, October 26 at 11:55 EDT / 16:55 CET, open regular session. | 1.2; substantially lower entry versus the morning's 6.3/10 at USD 7.19, alongside tighter earnings, BRL, capital and multiple scenarios. Three-year returns +95.3% / −49.0%. |
| November 2, 2026 | 6.6; dimensions unchanged at 6.0 / 8.0 / 6.0 / 7.0 / 6.0 | 7.8 | USD 4.01 October 30 regular close | 1.2; unchanged cautious scenarios, +124.5% / −41.3%. No new operating results. |
| November 9, 2026 | 6.6; dimensions unchanged at 6.0 / 8.0 / 6.0 / 7.0 / 6.0 | 7.8, unchanged | USD 3.86 November 6 regular close | 1.2; price down 3.7%; same assumptions, +133.3% / −39.0%; no change in business strength. |
| November 16, 2026 — Q3 | 6.7; dimensions 6.1 / 8.0 / 6.1 / 7.1 / 6.3 | 7.7 | USD 4.15 November 13 regular close | 1.2; better evidence for scale, economics and capital, with incomplete credit recovery. Earnings assumptions BRL 2.4bn or 1.2bn unchanged; +117.0% / −43.3%. |
Historical version-1.0 entries retain their original numerical values, with whole numbers displayed in decimal notation. They are not retrospective version-1.2 assessments. Direct comparison of the score series would require consistent methodology; no such historical recalculation has been performed. The new version allows tenths and a 1–10 scale; changing the version label alone does not justify a changed judgment.
Source-quality check: The August 5, 2026 press release describes 34% earnings growth as quarter over quarter; IFRS statements instead confirm year-over-year growth from BRL 315 to BRL 421 million, while growth from BRL 395 million in Q1 2026 is 6.6%. The analysis uses financial statements and comparable periods. The claim of achieving Rule of 50 remains management's interpretation; the stated metrics sum to 48.0%.
Sources
- Q2 2026 transcript, call August 6, 2026 — Q2 2026; main operational developments, underwriting, funding and methodology explanations.
- Q1 2026 transcript, call May 7, 2026 — Q1 2026; comparison base and early private payroll risks.
- Owners’ Day, May 2026 — transcript and official presentation for the May 11, 2026 event — strategic assumptions through 2029, ROE bridge and Rule of 50; these are management plans.
- Q2 2026 earnings release, published August 5, 2026 — precise KPIs, methodologies, capital and historical Q2 2026 comparison series.
- Financial statements at June 30, 2026 and their SEC version, dated August 5, 2026 — diluted EPS, shares, equity and earnings attributable to shareholders.
- Ownership as of October 13, 2026, INTR October 23 close of USD 7.19 — StockAnalysis and WSJ cross-check — governance, verified share count and reference valuation. Investing.com also supports daily quote history.
- BDR-program termination notice and timetable, listed in IR as a September 8, 2026 6-K — planned steps from September through November 2026.
- Investment analysis rules — reread October 26, 2026, current version 1.2 effective October 16, 2026.
- IR calendar — planned Q3 2026 results, indexed official content checked October 26, 2026; publication date is unstated. Release planned for November 12 after market close and call for November 13; these are planned, not completed events.
- SEC confirmation of the BDR election period, dated September 16, 2026 — election ends October 16 at 3:00 p.m. Brazilian time; supplements the original timetable without changing the economic scores.
Scope and uncertainty: Q2 2026 remains the latest earnings baseline. The post-election update changes valuation and analytical scenario assumptions, rather than constituting a new earnings analysis or complete business-strength reassessment. Persistence of BRL weakness and actual effects on rates, collections and earnings are not yet established. Complete coverage of newer announcements is not confirmed. The company says the BDR sales facility continues no later than November 17; final sold volume, average price and payment date have not been published, so its contribution to the price decline cannot be determined.
- Management structure change — SEC, October 13, 2026 — organizational announcement rather than a new earnings period.
- IR BDR FAQ, checked October 26, 2026, publication date unstated — INBR34 trading from October 19, elected INBR34 delivery by October 21 and sales facility October 19–November 17.
- 6-K and notice starting the subsequent BDR period, published October 19, 2026 — end of INBR32, start of INBR34, crediting elected INBR34 on October 21 and sales facility lasting no later than November 17.
The official release, presentation and IFRS filings support reported figures; the November 13 earnings call is the source of management views on automatic relinkage, insurance, credit costs and the pace of earnings normalization. Later-stage delinquency and sequential risk-adjusted margins remain the counterweight. Q3 results · Q3 presentation · IFRS statements
Was this analysis useful to you?